Fierce Biotech News & Reports
6 days ago · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Fierce Biotech Layoff Tracker 2024
2 days ago · March—18 companies. March 29 - Mustang Bio: Cell therapy-focused Mustang has laid off an undisclosed number of workers. The company declined to disclose how many employees would be impacted ...
Genentech inks $850M upfront deal for Regor's CDK inhibitors
Sep 30, 2024 · Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in ...
A look at the R&D landscape in obesity, led by GLP-1s - Fierce …
Mar 19, 2024 · If you’re feeling like overnight obesity became the indication du jour, you’re not alone. Novo Nordisk was granted approval for semaglutide to be marketed as Wegovy for chronic weight ...
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Oct 4, 2024 · Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay, at ...
MedTech | Fierce Biotech
6 days ago · The U.S. Preventive Services Task Force updated its guidelines for cervical cancer screening, endorsing HPV testing over Pap smears for certain women.
Upstream swells IPO to $255M as it lists alongside CAMP4
Oct 11, 2024 · Upstream Bio has swollen its IPO up to $255 million as the company joins CAMP4 this morning in becoming the latest biotechs to list on the Nasdaq.
Alcon’s $770M Aerie takeover delivers phase 3 dry eye wins
Jan 10, 2024 · Alcon’s $770 million takeover of Aerie Pharmaceuticals has delivered an early win. The lead candidate in the acquired pipeline met the primary endpoint in a pair of phase 3 dry eye trials ...
Layoff Tracker 2023 - Fierce Biotech
Dec 29, 2023 · We had hoped that our Layoff Tracker would stay retired for a while. We certainly had no plans to bring it back within the same week, but 2023 is starting to look a lot like our old friend 2022 ...
Viking to charge quickly into phase 3 with obesity med - Fierce …
Jul 25, 2024 · Viking Therapeutics will launch a longship into phase 3 for the obesity drug VK2735 sooner than expected, with a clinical program expected to top $300 million.
Skip to content